Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
E-pub ahead of print

2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Cardiac chamber volumes and left ventricular mass in people living with HIV and matched uninfected controls

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Risk factors during pregnancy and birth-related complications in HIV-positive versus HIV-negative women in Denmark, 2002-2014

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The EuroSIDA study: 25 years of scientific achievements

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Renal function in Ethiopian HIV-positive adults on antiretroviral treatment with and without tenofovir

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. How to RESPOND to Modern Challenges for People Living with HIV: A Profile for a New Cohort Consortium

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The EuroSIDA study: 25 years of scientific achievements

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Management of patients with multidrug-resistant tuberculosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • EACS Governing Board
Vis graf over relationer

BACKGROUND: The European AIDS Clinical Society (EACS) Guidelines cover key aspects of HIV management with major updates every two years.

GUIDELINE HIGHLIGHTS: The 2019 Guidelines were extended with a new section focusing on drug-drug interactions and other prescribing issues in people living with HIV (PLWH). The recommendations for treatment-naïve PLWH were updated with four preferred regimens favouring unboosted integrase inhibitors. A two-drug regimen with dolutegravir and lamivudine, and a three-drug regimen including doravirine were also added to the recommended initial regimens. Lower thresholds for hypertension were expanded to all PLWH and for cardiovascular disease prevention, the 10-year predicted risk threshold for consideration of antiretroviral therapy (ART) modification was lowered from 20% to 10%. Frailty and obesity were added as new topics. It was specified to use urine albumin to creatinine ratio to screen for glomerular disease and urine protein to creatinine ratio for tubular diseases, and thresholds were streamlined with the Kidney Disease: Improving Global Outcomes (KDIGO) recommendations. Hepatitis C virus (HCV) treatment recommendations were split into preferred and alternative treatment options. The algorithm for management of recently acquired HCV infection was updated and includes recommendations for early chronic infection management. Treatment of resistant tuberculosis (TB) was streamlined with the World Health Organization (WHO) recommendations, and new tables on immune reconstitution inflammatory syndrome, on when to start ART in the presence of opportunistic infections and on TB drug dosing were included.

CONCLUSIONS: The EACS Guidelines underwent major revisions of all sections in 2019. They are available in four different formats including a new interactive web-based version and are translated into Chinese, French, German, Japanese, Portuguese, Russian and Spanish.

OriginalsprogEngelsk
TidsskriftHIV Medicine
ISSN1464-2662
DOI
StatusE-pub ahead of print - 3 sep. 2020

Bibliografisk note

© 2020 The Authors. HIV Medicine published by John Wiley & Sons Ltd on behalf of British HIV Association.

ID: 60792164